Background: Seizure threshold (ST) varies in patients that undergo electroconvulsive therapy (ECT). It is therefore necessary to titrate for optimal energy levels at the beginning of each treatment session. Titration for ST is crucial for achieving the best treatment results while minimizing the side effects. Most patients undergoing ECT take concomitant psychotropic medication, but little information is available on how those drugs affect ST.
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Abstract Objects: The aim of the study was to review the pattern of electroconvulsive therapy(ECT) use in Korea and opinion of psychiatrist about ECT. Methods: We obtained ECT practice data from Korea health insurance review &assessment service. And survey was conducted to obtain opinion about ECT for psychiatrist by using 28-item questionnaire. Results: In 2014, 250 patients received ECT in Korea, overall numbers of ECT treatment were 2303. Treated Person Rates per 10,000 resident population per year was 0.05 and psychiatric inpatient prevalence of ECT was 0.003%. 88% of patients were administered Modified ECT. Affective disorder (47%) was main diagnostic indication and schizophrenia and schizoaffective disorder was 35%. 47% of patients were Female, and 29% were elderly (over 60 years). In survey, psychiatrist (n=145) reported ECT is safe (83.5%), effective(92.4%), necessary medical treatment (91.0%) and less used in Korea. (88.2%) Restriction factor of ECT using in Korea were negative attitude of patient and family members, lack of ECT facility, insufficient experience of psychiatrist, and low medical insurance fee. Conclusion: ECT use in Korea were very low compare with other OECD country and restriction factor were various. Considering of highest suicide ratio and risk of mental health in Korea, effort for activating ECT practice is required. Results: Although, the notion of "sound mind" within the procedure of informed consent is one of the first/oldest emphasized within this valuable and inevitable bioethical principle, restrictions introduced within the new Law regarding "surrogate or proxy decision making" seem to be rigid and regressive, resulting in the significant decline in the interest, number, and quality of biomedical research within this specific field, evident from the day of introduction of the Law. The position and practical function of the National Board conceived as the guardian of psychiatric patients' rights remain elusive, paradoxically possibly contributing to their further stigmatisation. Conclusion: Vulnerability of psychiatric patients creates unique interdependencies between medical and legal system. For this interdependency to be sucessful and in the best interest of those served, the intentions of "other part" should be respected and properly valued.
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